Wendi Grasman
Allergy & Immunology · Muskegon, MINPI 1285855346
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 299 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations.
Across 299 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$782
- Regeneron Healthcare Solutions, Inc.$425
- Takeda Pharmaceuticals U.S.A., Inc.$400
- Boehringer Ingelheim$369
- Novartis$365
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,80299%
- Education$781%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 44 | $1,073 |
| GSK | 67 | $782 |
| Regeneron Healthcare Solutions, Inc. | 17 | $425 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $400 |
| Boehringer Ingelheim | 20 | $369 |
| Novartis | 18 | $365 |
| Grifols USA, LLC | 14 | $334 |
| CSL Behring | 15 | $331 |
| Genentech USA, Inc. | 18 | $328 |
| Pharming Healthcare, Inc. | 8 | $196 |
| Phathom Pharmaceuticals, Inc. | 7 | $177 |
| Amgen | 7 | $139 |
| Pfizer | 6 | $128 |
| AbbVie | 6 | $123 |
| Biocryst US Sales Co., LLC | 5 | $103 |
| Blueprint Medicines Corporation | 2 | $72 |
| Kaleo, Inc. | 4 | $68 |
| Cycle Pharmaceuticals Inc | 2 | $48 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $44 |
| Mylan Specialty L.p. | 2 | $43 |
| Sanofi | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Alk-abello, Inc | 2 | $40 |
| Philips North America LLC | 2 | $35 |
| LEO Pharma Inc. | 2 | $33 |
| Incyte Corporation | 1 | $29 |
| Optinose US, Inc. | 2 | $27 |
| Ionis Pharmaceuticals, Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $22 |
| Aytu Biopharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOQUEZNA$125
How this compares
$5,880 in reported general payments places this provider in the 65th percentile of 119 allergy & immunology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 14 | $205 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Muskegon
- Frederick DetorresMuskegon$24K
- Steven StrykCanton$949K
- Hassan NasirWest Branch$736K
- Theodore KelbelGrand Rapids$695K
- Nicholas HartogGrand Rapids$575K
- Kathleen DassOak Park$446K
- Pulin PatelMount Clemens$431K
- Alan BaptistAnn Arbor$168K
- Mohsen NasirSaginaw$99K
- Abdul Husein BahrainwalaRoyal Oak$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.